Cercar

Barra de cerca
01/12/2023 Melanoma-specific survival in worse in the elderly: a multicentric cohort study.
Segura S, Podlipnik S, Boada A, Martí RM, Sabat M, Yélamos O, Zarzoso-Muñoz I, Azón-Masoliver A, López-Castillo D, Solà J, Baliu-Piqué C, Galvany-Rossell L, Pasquali P, Just-Sarobé M, Duran X, Carrera C, Richarz NA, Pujol RM, Malvehy J, Puig S. Melanoma-specific survival in worse in the elderly: a multicentric cohort study.. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000923. PMID:37696262. IF:1.500(Q3/7D).
01/12/2023 Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response
Carmona-Rocha, E, Sullivan, I, Yélamos, O. Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000918. PMID:37890183. IF:1.500(Q3/7D).
01/12/2023 High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome
Blanco, G, López-Aventín, D, Pujol, RM, Gómez-Llonín, A, Puiggros, A, López-Sánchez, M, Estrach, T, García-Muret, MP, López-Lerma, I, Servitje, O, Bellosillo, B, Muro, M, Espinet, B, Rabionet, R, Gallardo, F. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2023; 37(23-24)DOI:10.1002/jcla.24982. PMID:38115685. IF:2.600(Q2/5D).
20/11/2023 Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
Pereyra-Rodriguez, JJ, Baldrich, ES, Ruiz-Villaverde, R, Torres, EB, Dobao, PD, Nart, IF, Menéndez, AF, Martin-santiago, A, Miquel, JM, Silvestre, JF, Armario-Hita, JC. Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.12314. PMID:37982727. IF:3.500(Q1/3D).
14/11/2023 Non-invasive Skin Imaging in Cutaneous Lymphomas
Taleb, E, Yélamos, O, Ardigo, M, Christensen, RE, Geller, S. Non-invasive Skin Imaging in Cutaneous Lymphomas. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2023; 25(1)DOI:10.1007/s40257-023-00824-1. PMID:37964050. IF:8.600(Q1/1D).
06/11/2023 Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials
Yosipovitch, G, Lio, PA, Rosmarin, D, Serra-Baldrich, E, Legat, FJ, Casillas, M, Pierce, E, Liu, ZQ, Sun, LN, Elmaraghy, H, Ständer, S. Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials. BRITISH JOURNAL OF DERMATOLOGY. 2023; 190(2)DOI:10.1093/bjd/ljad435. PMID:37939793. IF:11.000(Q1/1D).